8-K filing — Glucotrack, Inc. (GCTK)
Filed: 2026-08-28 AccNo: 0001493152-26-040653 Size: 269 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Glucotrack's Lōkahi Therapeutic Subsidiary Initiates Good Manufacturing Practice Production Campaign For LT-100
Lōkahi Therapeutics™ Inc., a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced that it has started its initial Good Manufacturing Practice (GMP) manufacturing campaign for LT-100 (pure honeybee venom), the
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K/A filing — Glucotrack, Inc. (GCTK)
Filed: 2026-08-28 AccNo: 0001493152-26-040600 Size: 1 MB Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits
Glucotrack shares are trading lower after the company announced 1-for-15 reverse stock split, effective August 31.
Glucotrack Announces 1-For-15 Reverse Stock Split Effective August 31